Pfizer

UPDATE 3-FDA staff have concerns over key Arpida drug? 34 mins ago

By Sam Cage and Katie Reid NEW YORK/ZURICH, Nov 18 (Reuters) - There are key concerns about the efficacy and safety of Arpida's key drug iclaprim, U.S. regulatory staff said on Tuesday, and analysts said approval now looked...

Reuters Summit-UPDATE 2-Amgen tumor-starving drug gets spotlight? 1 hr ago

By Ransdell Pierson NEW YORK, Nov 18 (Reuters) - "It's new, we're ahead of the field and it has potential in a number of tumor types," Glenn Begley said at the Reuters Health Summit, calling the AMG 386 drug one of Amgen's most...

ValuEngine Upgrades The9 Ltd., Nexen, Pfizer To A '5' Rating

Nov 19, 2008 (financialwire.net via COMTEX) -- -- ValuEngine, Inc. (http://www.valuengine.com) upgraded five companies, including The9 Ltd (NASDAQ: NCTY), Nexen Inc (NYSE: NXY), Pfizer Inc (NYSE: PFE), and St Mary Land &...

Benitec Limited (ASX:BLT) Chairman's Address To Shareholders

Melbourne, Australia, Nov 19, 2008 - (ABN Newswire) - This again has been a challenging but significant year for Benitec. The past year has continued the major rebuilding of the Company.We have successfully strengthened the...

Nevada sues two makers of hormone drugs

The Nevada attorney general filed a lawsuit Tuesday against Wyeth Pharmaceuticals Inc. and Pfizer Inc., saying the drug giants misled the public about the safety of their hormone therapy drugs used by women to counter the...

Model N High Tech Revenue Management Suite Selected by STMicroelectronics to Optimize Price and M..

Semiconductor Leader Leverages Proven Model N Solutions to Improve Price and Deal Management and Improve Visibility Globally REDWOOD SHORES, CA--(Marketwire - Model N, the leader in Revenue Management solutions, today announced...

High Growth Reported for the World Pharmaceuticals Market Brief

NEW YORK (Business Wire) -- Punctuated with 18 statistically rich tables, the global market discussion offers special preludes to major market segments, such as, Prescription Drugs, Blockbuster Drugs, Anti-Depressants, COPD,...

Crestor carries broader benefits, AstraZeneca-funded study shows

Crestor can benefit people with higher levels of inflammation protein By Steve Goldstein, MarketWatch LONDON (MarketWatch) -- A large-scale study of AstraZeneca's anti-cholesterol drug has been shown to cut heart-attack risk...

Amgen to be 'opportunistic' on deals

By Deena Beasley and Bill Berkrot NEW YORK (Reuters) - Amgen Inc (AMGN.O: ) will be "opportunistic" in licensing or acquiring new cancer drug candidates, but there is little to tempt the biotechnology giant these days, said...

Diabetes rates increase in the kingdom recording the highest levels internationally

The internal medicine department of the King Abdul Aziz Medical City in Jeddah organized the Second Diabetes Symposium in collaboration with the Saudi Medical Association and sponsored by Pfizer Inc. - Saudi Arabia.

1 2 3 4 5 next »